TGF-β: The connecting link between nephropathy and fibrosis

Immunopharmacology and Immunotoxicology

Volumn 38, Issue 1, 2016, Pages 39-49

  Sutariya, Brijesh ^a   Jhonsa, Dimple ^a   Saraf, Madhusudan N ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

diabetic nephropathy; Epithelial to mesenchymal transition; membranous nephropathy; renal fibrosis; TGF

Indexed keywords

BETA CATENIN; INTEGRIN LINKED KINASE; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RHO KINASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

DIABETIC NEPHROPATHY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; KIDNEY DISEASE; KIDNEY FIBROSIS; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY; ANIMAL; EXTRACELLULAR MATRIX; FIBROSIS; IMMUNOLOGY; PATHOLOGY;

ANIMALS; DIABETIC NEPHROPATHIES; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROSIS; HUMANS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84957611389     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2015.1127382     Document Type: Review

References (139)

1. Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int 2005; 68: S7-S10
2. Schnaper HW, Jandeska S, Runyan CE, et al. TGF-beta signal transduction in chronic kidney disease. Front Biosci 2009; 14: 2448-2465
3. Lan HY. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. Int J Biol Sci 2011; 7: 1056-1067
4. Branton MH, Kopp JB. TGF-beta and fibrosis. Microbes Infect 1999; 1: 1349-1365
5. Chen S, Hong SW, Iglesias-dela Cruz MC, et al. The key role of the transforming growth factor-β system in the pathogenesis of diabetic nephropathy. Ren Fail 2001; 23: 471-481
6. Hills CE, Squires PE. The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev 2011; 22: 131-139
7. Mauer SM, Steffes MW, Ellis EN, et al. Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984; 74: 1143-1155
8. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010; 21: 212-222
9. Strutz F, Zeisberg M. Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 2006; 17: 2992-2998
10. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001; 159: 1465-1475
11. Son H, Moon A. Epithelial-mesenchymal transition and cell invasion. Toxicol Res 2010; 26: 245-252
12. Hertig A, Anglicheau D, Verine J, et al. Early epithelial phenotypic changes predict graft fibrosis. J Am Soc Nephrol 2008; 19: 1584-1591
13. Togawa H, Nakanishi K, Mukaiyama H, et al. Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease. Am J Physiol Renal Physiol 2011; 300: F511-F520
14. Boonla C, Krieglstein K, Bovornpadungkitti S, et al. Fibrosis and evidence for epithelial-mesenchymal transition in the kidneys of patients with staghorn calculi. BJU Int 2011; 108: 1336-1345
15. Iwano M, Plieth D, Danoff TM, et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350
16. Schnaper HW, Hayashida T, Hubchak SC, Poncelet A-C. TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 2003; 284: F243-F252
17. Rastaldi MP, Ferrario F, Giardino L, et al. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 2002; 62: 137-146
18. Boor P, Ostendorf T, Floege J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 2010; 6: 643-656
19. Galichon P, Hertig A. Epithelial to mesenchymal transition as a biomarker in renal fibrosis: are we ready for the bedside. Fibrogenesis Tissue Repair 2011; 4: 11
20. Kriz W, Kaissling B, Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 2011; 121: 468-474
21. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428
22. Humphreys BD, Lin S-L, Kobayashi A, et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176: 85-97
23. Inoue T, Umezawa A, Takenaka T, et al. The contribution of epithelial-mesenchymal transition to renal fibrosis differs among kidney disease models. Kidney Int 2015; 87: 233-238
24. Massagué J, Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 2000; 19: 1745-1754
25. Li Y, Tan X, Dai C, et al. Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis. J Am Soc Nephrol 2009; 20: 1907-1918
26. Wu Y, Zhou BP. New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Bioch Bioph Sin 2008; 40: 643-650
27. Jiang YG, Luo Y, He D, et al. Role of Wnt/β-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1α. Int J Urol 2007; 14: 1034-1039
28. Lan HY. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens 2003; 12: 25-29
29. Bedi S, Vidyasagar A, Djamali A. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev (Orlando) 2008; 22: 1-5
30. Fan J-M, Huang X-R, Ng Y-Y, et al. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-β1-dependent mechanism in vitro. Am J Kidney Dis 2001; 37: 820-831
31. Carvajal G, Rodríguez-Vita J, Rodrigues-Diéz R, et al. Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. Kidney Int 2008; 74: 585-595
32. Cheng S, Lovett DH. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am J Pathol 2003; 162: 1937-1949
33. Zhang G, Kernan KA, Collins SJ, et al. Plasmin (ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals. J Am Soc Nephrol 2007; 18: 846-859
34. Yang J, Shultz RW, Mars WM, et al. Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J Clin Invest 2002; 110: 1525-1538
35. Djamali A, Reese S, Yracheta J, et al. Epithelial-to-mesenchymal transition and oxidative stress in chronic allograft nephropathy. Am J Transplant 2005; 5: 500-509
36. Burns WC, Twigg SM, Forbes JM, et al. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 2006; 17: 2484-2494
37. Dennler S, Goumans M-J, Ten Dijke P. Transforming growth factor beta signal transduction. J Leukoc Biol 2002; 71: 731-740
38. Willis BC, Borok Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007; 293: L525-L534
39. Todorovic V, Jurukovski V, Chen Y, et al. Latent TGF-beta binding proteins. Int J Biochem Cell Biol 2005; 37: 38-41
40. Kojima S, Nara K, Rifkin DB. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol 1993; 121: 439-448
41. Koli K, Saharinen J, Hyytiaïnen M, et al. Latency, activation, and binding proteins of TGF-beta. Microsc Res Techniq 2001; 52: 354-362
42. Crawford SE, Stellmach V, Murphy-Ullrich JE, et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998; 93: 1159-1170
43. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296: 1655-1657
44. Mu D, Cambier S, Fjellbirkeland L, et al. The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-β1. J Cell Biol 2002; 157: 493-507
45. Cheifetz S, Weatherbee JA, Tsang ML-S, et al. The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell 1987; 48: 409-415
46. Moustakas A, Heldin C-H. The regulation of TGFbeta signal transduction. Development 2009; 136: 3699-3714
47. Tsukazaki T, Chiang TA, Davison AF, et al. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 1998; 95: 779-791
48. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425: 577-84
49. Phanish M, Wahab N, Colville-Nash P, et al. The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. Biochem J 2006; 393: 601-607
50. Massagué J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005; 19: 2783-2810
51. Piek E, Moustakas A, Kurisaki A, et al. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci 1999; 112: 4557-4568
52. Hayashi H, Abdollah S, Qiu Y, et al. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 1997; 89: 1165-1173
53. Nakao A, Afrakhte M, Morn A, et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 1997; 389: 631-635
54. Akiyoshi S, Inoue H, Hanai J-I, et al. c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with Smads. J Biol Chem 1999; 274: 35269-35277
55. Luo K. Ski and SnoN: negative regulators of TGF-beta signaling. Curr Opin Genet Dev 2004; 14: 65-70
56. Stroschein SL, Wang W, Zhou S, et al. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science 1999; 286: 771-774
57. Kavsak P, Rasmussen RK, Causing CG, et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 2000; 6: 1365-1375
58. Yang J, Dai C, Liu Y. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J Am Soc Nephrol 2005; 16: 68-78
59. Sato M, Muragaki Y, Saika S, et al. Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003; 112: 1486-1494
60. Yang F, Huang XR, Chung AC, et al. Essential role for Smad3 in angiotensin II-induced tubular epithelial-mesenchymal transition. J Pathol 2010; 221: 390-401
61. Ju W, Ogawa A, Heyer J, et al. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol 2006; 26: 654-667
62. Saika S, Ikeda K, Yamanaka O, et al. Adenoviral gene transfer of BMP-7, Id2, or Id3 suppresses injury-induced epithelial-to-mesenchymal transition of lens epithelium in mice. Am J Physiol Cell Physiol 2006; 290: C282-C289
63. Zeisberg M, Hanai J-i, Sugimoto H, et al. BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9: 964-968
64. Zhong X, Chung AC, Chen H-Y, et al. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 2011; 22: 1668-1681
65. Zhou Q, Chung AC, Huang XR, et al. Identification of novel long noncoding RNAs associated with TGF-β/Smad3-mediated renal inflammation and fibrosis by RNA sequencing. Am J Pathol 2014; 184: 409-417
66. Moustakas A, Heldin C-H. Non-Smad TGF-beta signals. J Cell Sci 2005; 118: 3573-3584
67. Atfi A, Djelloul S, Chastre E, et al. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor β-mediated signaling. J Biol Chem 1997; 272: 1429-1432
68. Hanafusa H, Ninomiya-Tsuji J, Masuyama N, et al. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-β-induced gene expression. J Biol Chem 1999; 274: 27161-27167
69. Edlund S, Landström M, Heldin C-H, Aspenström P. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol Biol Cell 2002; 13: 902-914
70. Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001; 12: 27-36
71. Bakin AV, Tomlinson AK, Bhowmick NA, et al. Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000; 275: 36803-36810
72. Bielesz B, Sirin Y, Si H, et al. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 2010; 120: 4040-4054
73. Zhang P, Cai Y, Soofi A, Dressler GR. Activation of Wnt11 by transforming growth factor-β drives mesenchymal gene expression through non-canonical Wnt protein signaling in renal epithelial cells. J Biol Chem 2012; 287: 21290-21302
74. Masszi A, Fan L, Rosivall L, et al. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J Pathol 2004; 165: 1955-1967
75. Tian W, Zhang Z, Cohen DM. MAPK signaling and the kidney. Am J Physiol Renal Physiol 2000; 279: F593-F604
76. Yang C, Patel K, Harding P, et al. Regulation of TGF-β1/MAPK-mediated PAI-1 gene expression by the actin cytoskeleton in human mesangial cells. Exp Cell Res 2007; 313: 1240-1250
77. Force T, Bonventre JV. Growth factors and mitogen-activated protein kinases. Hypertension 1998; 31: 152-161
78. Hayashida T, Decaestecker M, Schnaper HW. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-β-dependent responses in human mesangial cells. FASEB J 2003; 17: 1576-1578
79. Ma FY, Flanc RS, Tesch GH, et al. A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. J Am Soc Nephrol 2007; 18: 472-484
80. Hocevar BA, Brown TL, Howe PH. TGF-β induces fibronectin synthesis through ac-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 1999; 18: 1345-1356
81. Wysk M, Yang DD, Lu H-T, et al. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. Proc Natl Acad Sci USA 1999; 96: 3763-3768
82. Gruden G, Zonca S, Hayward A, et al. Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes 2000; 49: 655-661
83. Thornton TM, Pedraza-Alva G, Deng B, et al. Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science 2008; 320: 667-670
84. Bhowmick NA, Zent R, Ghiassi M, et al. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J Biol Chem 2001; 276: 46707-46713
85. Rodríguez-Barbero A, Dorado F, Velasco S, et al. TGF-β1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells. Kidney Int 2006; 70: 901-909
86. Yi JY, Shin I, Arteaga CL. Type I transforming growth factor β receptor binds to and activates phosphatidylinositol 3-kinase. J Biol Chem 2005; 280: 10870-10876
87. Docherty NG, OSullivan OE, Healy DA, et al. TGF-β1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation. Am J Physiol Renal Physiol 2006; 290: F1202-F1212
88. Kattla JJ, Carew RM, Heljić M, et al. Protein kinase B/Akt activity is involved in renal TGF-β1-driven epithelial-mesenchymal transition in vitro and in vivo. Am J Physiol Renal Physiol 2008; 295: F215-F225
89. Cho HJ, Baek KE, Saika S, et al. Snail is required for transforming growth factor-β-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochem Biophys Res Commun 2007; 353: 337-343
90. Boutet A, De Frutos CA, Maxwell PH, et al. Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J 2006; 25: 5603-5613
91. Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009; 19: 156-172
92. Masszi A, Di Ciano C, Sirokmány G, et al. Central role for Rho in TGF-β1-induced α-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol 2003; 284: F911-F924
93. Ozdamar B, Bose R, Barrios-Rodiles M, et al. Regulation of the polarity protein Par6 by TGFß receptors controls epithelial cell plasticity. Science 2005; 307: 1603-1609
94. Schweisguth F. Regulation of notch signaling activity. Curr Biol 2004; 14: R129-R138
95. Zavadil J, Cermak L, Soto-Nieves N, et al. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 2004; 23: 1155-1165
96. Niimi H, Pardali K, Vanlandewijck M, et al. Notch signaling is necessary for epithelial growth arrest by TGF-beta. J Cell Biol 2007; 176: 695-707
97. Böttinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol 2002; 13: 2600-2610
98. Ilagan MXG, Kopan R. SnapShot: notch signaling pathway. Cell 2007; 128: 1246
99. Tan RJ, Zhou D, Zhou L, Liu Y. Wnt/β-catenin signaling and kidney fibrosis. Kidney Int Suppl 2014; 4: 84-90
100. Li Y, Yang J, Dai C, et al. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 2003; 112: 503-516
101. Guo L, Sanders PW, Woods A, Wu C. The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys. Am J Pathol 2001; 159: 1735-1742
102. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004; 15: 1-12
103. Legate KR, Montañez E, Kudlacek O, Füssler R. ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol 2006; 7: 20-31
104. Zimmet P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787
105. Lee HS. Pathogenic role of tGF-β in diabetic nephropathy. J Diabetes Metab 2013; S9: 008
106. Sharma K, McGowan TA. TGF-β in diabetic kidney disease: role of novel signaling pathways. Cytokine Growth Factor Rev 2000; 11: 115-123
107. Kim Y, Kleppel M, Butkowski R, et al. Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 1991; 138: 413
108. Ayo SH, Radnik RA, Glass W, et al. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 1991; 260: F185-F191
109. Kang BP, Frencher S, Reddy V, et al. High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism. Am J Physiol Renal Physiol 2003; 284: F455-F466
110. Vidotti D, Casarini D, Cristovam P, et al. High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am J Physiol Renal Physiol 2004; 286: F1039-F1045
111. Lee HS. Pathogenic role of TGF-β in the progression of podocyte diseases. Histol Histopathol 2011; 26: 107-116
112. Rerolle J-P, Hertig A, Nguyen G, et al. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int 2000; 58: 1841-1850
113. Huang Y, Wongamorntham S, Kasting J, et al. Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int 2006; 69: 105-113
114. Wautier J, Guillausseau P. Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab 2001; 27: 535-542
115. Forbes JM, Cooper ME, Oldfield MD, Thomas MC. Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol 2003; 14: S254-S258
116. Yang C-W, Vlassara H, Peten EP, et al. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 1994; 91: 9436-9440
117. Wautier M-P, Chappey O, Corda S, et al. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endoc M 2001; 280: E685-E694
118. Kitsiou PV, Tzinia AK, Stetler-Stevenson WG, et al. Glucose-induced changes in integrins and matrix-related functions in cultured human glomerular epithelial cells. Am J Physiol Renal Physiol 2003; 284: F671-F679
119. Munger JS, Huang X, Kawakatsu H, et al. The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999; 96: 319-328
120. Koli K, Myllärniemi M, Keski-Oja J, Kinnula VL. Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid Redox Signal 2008; 10: 333-342
121. Pezzolesi MG, Satake E, McDonnell KP, et al. Circulating TGF-β1-regulated miRNAs and the risk of rapid progression to ESRD in type 1 diabetes. Diabetes 2015; 64: 3285-3293
122. Krupa A, Jenkins R, Luo DD, et al. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 2010; 21: 438-447
123. Putta S, Lanting L, Sun G, et al. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol 2012; 23: 458-469
124. Wang Q, Wang Y, Minto AW, et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 2008; 22: 4126-4135
125. Du B, Ma L-M, Huang M-B, et al. High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells. FEBS Lett 2010; 584: 811-816
126. Bonegio RG, Fuhro R, Wang Z, et al. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. J Am Soc Nephrol 2005; 16: 2063-2072
127. Schieppati A, Ruggenenti P, Perna A, Remuzzi G., editors. Nonimmunosuppressive therapy of membranous nephropathy. Semin Nephrol 2003; 23: 333-339
128. Couser WG, Nangaku M. Cellular and molecular biology of membranous nephropathy. J Nephrol 2005; 19: 699-705
129. Ronco P, Debiec H. Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization. J Am Soc Nephrol 2005; 16: 1205-1213
130. Kim TS, Kim JY, Hong HK, Lee HS. mRNA expression of glomerular basement membrane proteins and TGF-β 1 in human membranous nephropathy. J Pathol 1999; 189: 425-430
131. Ren G, Huynh C, Bijian K, Cybulsky AV. Role of apoptosis signal-regulating kinase 1 in complement-mediated glomerular epithelial cell injury. Mol Immunol 2008; 45: 2236-2246
132. Mudge SJ, Paizis K, Auwardt RB, et al. Activation of nuclear factor-&kgr; B by podocytes in the autologous phase of passive Heymann nephritis. Kidney Int 2001; 59: 923-931
133. Zahner G, Harendza S, Muller E, et al. Prostaglandin E2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesangial cells. Kidney Int 1997; 51: 1116-1123
134. Jobling MF, Mott JD, Finnegan MT, et al. Isoform-specific activation of latent transforming growth factor β (LTGF-β) by reactive oxygen species. Radiat Res 2006; 166: 839-848
135. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000; 14: 163-176
136. Gao L, Qiu W, Wang Y, et al. Sublytic complement C5b-9 complexes induce thrombospondin-1 production in rat glomerular mesangial cells via PI3-k/Akt: association with activation of latent transforming growth factor-β1. Clin Exp Imm 2006; 144: 326-334
137. Kim JH, Kim BK, Moon KC, et al. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis. Kidney Int 2003; 64: 1715-1721
138. Wahab N, Schaefer L, Weston B, et al. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Diabetologia 2005; 48: 2650-2660
139. Hugo C, Shankland SJ, Pichler RH, et al. Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat. Kidney Int 1998; 53: 302-311